Erlotero - Erlotinib

Generic Name:

Erlotinib

Storage Condition:

Store below 30°C

Packing:

30 Tablet

Mfg / Mkd By:

Hetero Healthcare ltd

Doses:


Therapeutic Use:

Cancer

Description:

Introduction ERLOTERO 150MG TABLET:

ERLOTERO 150MG TABLET contains Erlotinib which belongs to the group of medicines called Kinase inhibitors. It is used in adults to manage non-small cell lung cancer at an advanced stage, as initial therapy (or as therapy if disease remains largely unchanged after initial chemotherapy, provided your cancer cells have specific EGFR mutations).

It is also used if previous chemotherapy has not helped to stop the disease and to manage cancer of the pancreas at a metastatic stage in combination with gemcitabine. Cancer can be defined as body cells beginning to grow out of control. Cells in any part of the body can become cancer cells and can spread to other areas of the body. Your doctor may perform certain blood tests prior to the management.

Avoid smoking during the management of ERLOTERO 150MG TABLET, as it decreases the effect of the medicine. ERLOTERO 150MG TABLET is not recommended for use if you have severe liver or kidney disease. Before taking ERLOTERO 150MG TABLET inform your doctor if you have diarrhea, glucuronidation disorder like Gilbert’s syndrome, history of peptic ulcers or diverticular disease, you use contact lenses, or have a history of eye problems (severe dry eyes, inflammation or ulcers of the cornea).

ERLOTERO 150MG TABLET is generally not recommended for use in pregnant and breastfeeding women unless considered clearly necessary, therefore consult your doctor before taking it. ERLOTERO 150MG TABLET is not recommended for use in children and adolescents below 18 years of age. The most common side effects of taking ERLOTERO 150MG TABLET are rash, infection, loss of appetite, decreased weight, or depression. Contact your doctor if any of the symptoms worsen.

Uses of ERLOTERO 150MG TABLET:

  • non-small cell lung cancer at an advanced stage
  • initial cancer stage (or as therapy if disease remains largely unchanged after initial chemotherapy)
  • pancreatic cancer at a metastatic stage in combination with gemcitabine

How to consume ERLOTERO 150MG TABLET:

Take ERLOTERO 150MG TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Do not take medicine with food. Your doctor will decide the correct dose and duration for you depending upon your age, body weight, and disease condition.

Our Other Products

View All
Lenalid

Lenalid 5 mg

Generic Name: Lenalidomide

Capsule
Packaging:1 X 30 Capsules
Mfg / Mfd By:Natco pharma ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Cancer
Ninlib

Ninlib 150 mg

Generic Name: Nilotinib

Capsule
Packaging:1 X 30 Capsules
Mfg / Mfd By:Hetero Helthcare ltd
Storage Condition:Store below 30°C
Therapeutic Use:
cancer
Tasigna

Tasigna 150 mg

Generic Name: Nilotinib

Capsule
Packaging:28 Capsule
Mfg / Mfd By:Novartis India Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Blood Cancer
Xbira

Xbira 250 mg

Generic Name: Abiraterone Acetate

Tablet
Packaging:120 Tablets
Mfg / Mfd By:Cipla LTD
Storage Condition:Store below 30°C
Therapeutic Use:
Prostate Cancer